In Stock, Ready to Ship!
Price range: $150.00 through $500.00 — or subscribe and save 20%
99% Pure | USA Made | Multi DoseGLP-2 T is a synthetic dual-agonist peptide targeting GLP-1 and GIP receptors, used in preclinical models to study glucose homeostasis, appetite-regulation, and energy-balance pathways. Available in 15 mg and 30 mg lyophilized vials, GLP-2 T peptide delivers precise receptor activation for in vitro and rodent assays. Each lot is USA-made, HPLC-verified to ≥ 99% purity, endotoxin-screened (< 0.1 EU/mg), and formulated for laboratory research.
Peptides are not ready to use. Must purchase BAC water for reconstitution.
Activates GLP-1 & GIP pathways together, so you can compare single vs combined incretin effects in the same assay.
Boosts insulin release in pancreatic β-cells, letting you map how Tirzepatide peptide affects blood-sugar regulation.
In rodent satiety studies, Tirzepatide reduces food-intake endpoints—ideal for neural-circuit and behavior assays.
In adipocyte cultures, it improves fat-burn markers, offering a direct window into lipid-oxidation pathways.
Engages AMPK and PPAR in muscle and liver cells, helping you probe how cells manage fuel and energy.
Simply dissolve in sterile or bacteriostatic water, store powder at –20 °C, and keep solution at 2–8 °C for 7 days.
KEY HIGHLIGHTS
Activates GLP-1 & GIP pathways together, so you can compare single vs combined incretin effects in the same assay.
Boosts insulin release in pancreatic β-cells, letting you map how Tirzepatide peptide affects blood-sugar regulation.
In rodent satiety studies, Tirzepatide reduces food-intake endpoints—ideal for neural-circuit and behavior assays.
In adipocyte cultures, it improves fat-burn markers, offering a direct window into lipid-oxidation pathways.
Engages AMPK and PPAR in muscle and liver cells, helping you probe how cells manage fuel and energy.
Simply dissolve in sterile or bacteriostatic water, store powder at –20 °C, and keep solution at 2–8 °C for 7 days.
Tirzepatide is a novel 39-amino-acid dual-agonist designed to activate both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. In research settings, Tirzepatide peptide enables dissection of incretin biology, allowing investigators to probe how combined receptor signaling influences insulin secretion, appetite control, and energy expenditure.
Choose Tirzepatide injections when you need a single-molecule tool to model the interplay of GLP-1 and GIP pathways in metabolic-health research. Its dual-agonist profile provides richer mechanistic insights than single-receptor peptides, supporting advanced studies in diabetes models, obesity assays, and cell-signaling protocols. Manufactured under ISO-certified conditions and verified to ≥ 99% HPLC purity with low endotoxin (< 0.1 EU/mg), Tirzepatide delivers consistent, high-fidelity results across both in vitro and in vivo experiments.
Tirzepatide peptide stands out by combining two incretin activities—GLP-1 and GIP—into one stable molecule with optimized pharmacokinetics for research applications. Unlike separate agonists, Tirzepatide produces synergistic effects on insulin release, satiety signals, and lipid metabolism, all while maintaining a clean receptor-specific profile. Its availability in both 15 mg and 30 mg vials lets labs tailor dose-response studies and translational rodent protocols with maximum flexibility.
It co-activates GLP-1/GIP receptors to study insulin release, appetite control, and energy-balance pathways.
By engaging both GLP-1 and GIP receptors on pancreatic β-cells, enhancing glucose-stimulated insulin release.
In vitro: 50 nM–1 µM; in vivo rodent: 0.1–0.5 mg/kg for dose-response and chronic-dosing studies.
Real Peptides offers ISO-certified, USA-manufactured Tirzepatide (15 mg & 30 mg) at ≥ 99% purity and low endotoxin—available for research use only.
Yes—central and peripheral dosing protocols demonstrate significant decreases in cumulative food-intake endpoints.
Dissolve in SWFI or BAC water per protocol, gently mix, and use immediately or store at 2–8 °C.
Store lyophilized Tirzepatide at – 20 °C; use reconstituted peptide within 7 days at 2–8 °C.
In adipocyte assays, Tirzepatide upregulates AMPK and PPAR pathways, modeling increased lipid oxidation.
No—Tirzepatide peptide is strictly for research use only and not approved for therapeutic applications.
Common models include pancreatic islet assays, diet-induced obesity rodents, and central appetite-regulation studies.
Don't hestitate to contact us
End of Content.
